{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:11:07Z","timestamp":1792390267377,"version":"4.4.0"},"reference-count":346,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.addr.2023.115084","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T02:13:33Z","timestamp":1694052813000},"page":"115084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Up-to-date molecular medicine strategies for management of ocular surface neovascularization"],"prefix":"10.1016","volume":"201","author":[{"given":"Yunlong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-357X","authenticated-orcid":false,"given":"Lasse D","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4390","key":"10.1016\/j.addr.2023.115084_b0005","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1167\/iovs.07-0770","article-title":"The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture","volume":"48","author":"Gipson","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000099253","article-title":"Immune privilege and angiogenic privilege of the cornea","volume":"92","author":"Cursiefen","year":"2007","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.addr.2023.115084_b0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nm0909-993","article-title":"Blocking the path of lymphatic vessels","volume":"15","author":"Skobe","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2023.115084_b0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ACI.0b013e32833dfa11","article-title":"High-risk corneal allografts and why they lose their immune privilege","volume":"10","author":"Niederkorn","year":"2010","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2023.115084_b0030","doi-asserted-by":"crossref","unstructured":"B. Bachmann, R.S. Taylor, C. Cursiefen, Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis, Ophthalmology 117 (2010) 1300\u20131305 e1307.","DOI":"10.1016\/j.ophtha.2010.01.039"},{"key":"10.1016\/j.addr.2023.115084_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clae.2011.07.004","article-title":"Correlation of central and peripheral corneal thickness in healthy corneas","volume":"35","author":"Fares","year":"2012","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.addr.2023.115084_b0040","first-page":"3348","article-title":"The thickness of the human precorneal tear film: evidence from reflection spectra","volume":"41","author":"King-Smith","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.preteyeres.2012.06.002","article-title":"Tear analysis in ocular surface diseases","volume":"31","author":"Zhou","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exer.2010.07.007","article-title":"Mapping the entire human corneal nerve architecture","volume":"91","author":"He","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0065","first-page":"2517","article-title":"Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment","volume":"42","author":"Lin","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0070","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.115084_b0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1167\/iovs.11-8379","article-title":"Nerves and neovessels inhibit each other in the cornea","volume":"54","author":"Ferrari","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108457","article-title":"Corneal angiogenic privilege and its failure","volume":"204","author":"Di Zazzo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0090","series-title":"Ocular angiogenesis : diseases, mechanisms, and therapeutics","author":"Tombran-Tink","year":"2006"},{"key":"10.1016\/j.addr.2023.115084_b0095","first-page":"S593","article-title":"Prevalence of corneal neovascularization in a general eye service population","volume":"37","author":"Colby","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0100","article-title":"Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study","volume":"8","author":"Lasagni Vitar","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.addr.2023.115084_b0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"Suppl","key":"10.1016\/j.addr.2023.115084_b0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0039-6257(93)90036-7","article-title":"Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy","volume":"38","author":"Abelson","year":"1993","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/OPTO.S84795","article-title":"Diagnosis and management of blepharitis: an optometrist's perspective","volume":"8","author":"Putnam","year":"2016","journal-title":"Clin. Optom. (Auckl)"},{"key":"10.1016\/j.addr.2023.115084_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exer.2017.06.011","article-title":"Ocular surface inflammation impairs structure and function of meibomian gland","volume":"163","author":"Mizoguchi","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/02713683.2013.823212","article-title":"Progress in the pathogenesis of pterygium","volume":"38","author":"Liu","year":"2013","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0130","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.febslet.2008.06.014","article-title":"Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis","volume":"582","author":"Kojima","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2023.115084_b0135","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.addr.2023.115084_b0140","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0145","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000256","article-title":"Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity","volume":"5","author":"Chauhan","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.addr.2023.115084_b0150","doi-asserted-by":"crossref","unstructured":"Y. Cao, J. Arbiser, R.J. D'Amato, P.A. D'Amore, D.E. Ingber, R. Kerbel, M. Klagsbrun, S. Lim, M.A. Moses, B. Zetter, H. Dvorak, R. Langer, Forty-year journey of angiogenesis translational research, Sci. Transl. Med. 3 (2011) 114rv113.","DOI":"10.1126\/scitranslmed.3003149"},{"key":"10.1016\/j.addr.2023.115084_b0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis (Lond)"},{"key":"10.1016\/j.addr.2023.115084_b0160","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.addr.2023.115084_b0165","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0170","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.115084_b0175","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","article-title":"Vascular endothelial growth factor B, a novel growth factor for endothelial cells","volume":"93","author":"Olofsson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2023.115084_b0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/geno.1997.4774","article-title":"Molecular cloning of a novel vascular endothelial growth factor, VEGF-D","volume":"42","author":"Yamada","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.addr.2023.115084_b0190","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","volume":"88","author":"Maglione","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b0195","doi-asserted-by":"crossref","unstructured":"Y. Cao, Positive and negative modulation of angiogenesis by VEGFR1 ligands, Sci. Signal, 2 (2009) re1.","DOI":"10.1126\/scisignal.259re1"},{"key":"10.1016\/j.addr.2023.115084_b0200","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","article-title":"Hyperplasia of lymphatic vessels in VEGF-C transgenic mice","volume":"276","author":"Jeltsch","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.115084_b0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2023.115084_b0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2023.115084_b0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.03.011","article-title":"The impact of VEGF on cancer metastasis and systemic disease","author":"Yang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.addr.2023.115084_b0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0230","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0235","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/178132","article-title":"Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab","volume":"2014","author":"Krizova","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","article-title":"Topical ranibizumab as a treatment of corneal neovascularization","volume":"32","author":"Ferrari","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1167\/iovs.12-11032","article-title":"Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization","volume":"54","author":"Amparo","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/ijo.IJO_418_18","article-title":"Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery","volume":"67","author":"Aksoy","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0255","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ICL.0000000000000709","article-title":"Subconjunctival Aflibercept for the Treatment of Formed Corneal Neovascularization","volume":"47","author":"Sella","year":"2021","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.addr.2023.115084_b0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/02713680903429007","article-title":"Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model","volume":"35","author":"Avisar","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/112067211002000106","article-title":"VEGF Trap(R1R2) suppresses experimental corneal angiogenesis","volume":"20","author":"Oliveira","year":"2010","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0270","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00417-014-2626-2","article-title":"Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis","volume":"252","author":"Lipp","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0275","first-page":"136","article-title":"Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model","volume":"6","author":"Akar","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/02713681003597230","article-title":"A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization","volume":"35","author":"Zuo","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1096\/fj.201600746r","article-title":"miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways","volume":"31","author":"Park","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b0290","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.18632\/oncotarget.14370","article-title":"Subconjunctival injection of antagomir-21 alleviates corneal neovascularization in a mouse model of alkali-burned cornea","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2023.115084_b0295","doi-asserted-by":"crossref","unstructured":"J.J. Perez-Santonja, E. Campos-Mollo, M. Lledo-Riquelme, J. Javaloy, J.L. Alio, Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model, Am. J. Ophthalmol. 150 (2010) 519-528 e511.","DOI":"10.1016\/j.ajo.2010.04.024"},{"key":"10.1016\/j.addr.2023.115084_b0300","first-page":"220","article-title":"Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization","volume":"7","author":"Onder","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0305","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.18240\/ijo.2021.11.04","article-title":"Inhibition of corneal neovascularization by topical application of nintedanib in rabbit models","volume":"14","author":"Chen","year":"2021","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0310","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ICO.0b013e31823f8b9c","article-title":"Inhibition of corneal neovascularization in rats by systemic administration of sorafenib","volume":"31","author":"Seo","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0315","doi-asserted-by":"crossref","first-page":"44045","DOI":"10.1074\/jbc.M111.278754","article-title":"The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells","volume":"286","author":"Nacev","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.115084_b0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000366283","article-title":"Antiangiogenic effect of itraconazole on corneal neovascularization: a pilot experimental investigation","volume":"52","author":"Goktas","year":"2014","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.addr.2023.115084_b0325","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1111\/bph.13177","article-title":"Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization","volume":"172","author":"Kim","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2023.115084_b0330","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/ICO.0b013e3182a48009","article-title":"Subconjunctival injection of low-molecular-weight heparin-taurocholate 7 inhibits corneal neovascularization","volume":"32","author":"Yoon","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0335","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/ICO.0000000000000548","article-title":"Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo","volume":"34","author":"Lu","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jmf.2014.3404","article-title":"Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization","volume":"19","author":"Yang","year":"2016","journal-title":"J. Med. Food"},{"key":"10.1016\/j.addr.2023.115084_b0345","doi-asserted-by":"crossref","first-page":"30843","DOI":"10.1038\/srep30843","article-title":"Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCalpha, and PDGFR Targets","volume":"6","author":"Zong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b0350","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.intimp.2015.08.009","article-title":"AA092, an annonaceous acetogenin mimetic, attenuates angiogenesis in a mouse model of inflammation-induced corneal neovascularization","volume":"28","author":"Zhang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2023.115084_b0355","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/ICO.0000000000000104","article-title":"Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits","volume":"33","author":"Koh","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0360","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/18793","article-title":"Angiogenesis inhibited by drinking tea","volume":"398","author":"Cao","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.115084_b0365","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ICO.0b013e318241433b","article-title":"Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model","volume":"31","author":"Lee","year":"2012","journal-title":"Cornea"},{"issue":"Suppl","key":"10.1016\/j.addr.2023.115084_b0370","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.addr.2023.115084_b0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2023.115084_b0380","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","article-title":"Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance","volume":"28","author":"Iwamoto","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2023.115084_b0385","first-page":"485","article-title":"Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration","volume":"7","author":"Tranos","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2023.115084_b0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2023.115084_b0395","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1167\/iovs.05-1223","article-title":"FGF-2-induced wound healing in corneal endothelial cells requires Cdc42 activation and Rho inactivation through the phosphatidylinositol 3-kinase pathway","volume":"47","author":"Lee","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0400","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/mi.2017.26","article-title":"Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection","volume":"11","author":"Gurung","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2023.115084_b0405","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-012-2008-6","article-title":"The subconjunctival use of cetuximab and bevacizumab in inhibition of corneal angiogenesis","volume":"250","author":"Tunik","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0410","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1038\/mtna.2016.1","article-title":"Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization","volume":"5","author":"Taketani","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2023.115084_b0415","first-page":"359","article-title":"Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses","volume":"10","author":"Salcedo","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.addr.2023.115084_b0420","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","article-title":"Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2023.115084_b0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000358201","article-title":"The effect of TC14012 on alkali burn-induced corneal neovascularization in mice","volume":"52","author":"Shen","year":"2014","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.addr.2023.115084_b0430","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/02713683.2014.968934","article-title":"Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization","volume":"40","author":"Liu","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0435","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.exer.2007.06.004","article-title":"The role of integrin alpha5beta1 in the regulation of corneal neovascularization","volume":"85","author":"Muether","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0440","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-1-2","article-title":"Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis","volume":"1","author":"Cheng","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.addr.2023.115084_b0445","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.bjc.6604019","article-title":"Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase","volume":"97","author":"Rumjahn","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2023.115084_b0450","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-010-1457-z","article-title":"Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization","volume":"67","author":"Lopez","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2023.115084_b0455","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/glycob\/cwu086","article-title":"Galectin-3 in angiogenesis and metastasis","volume":"24","author":"Funasaka","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.addr.2023.115084_b0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.16-20009","article-title":"Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis","volume":"58","author":"Chen","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10384-007-0487-5","article-title":"Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor","volume":"52","author":"Hata","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0470","first-page":"2947","article-title":"ADP-ribosylation factor as a novel target for corneal neovascularization regression","volume":"18","author":"Dai","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2023.115084_b0475","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.14-14023","article-title":"Serine Proteinase Inhibitor SERPINA3K Suppresses Corneal Neovascularization via Inhibiting Wnt Signaling and VEGF","author":"Zhou","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0480","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1167\/iovs.05-1071","article-title":"The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization","volume":"47","author":"Dell","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0485","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11877","article-title":"Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2023.115084_b0490","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b0495","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-016-2372-3","article-title":"Proteins of the corneal stroma: importance in visual function","volume":"364","author":"Xuan","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.addr.2023.115084_b0500","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2023.115084_b0505","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/02713683.2010.502294","article-title":"Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors","volume":"35","author":"Shi","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0510","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization","volume":"70","author":"Kvanta","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0515","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/452685","article-title":"Inhibition of corneal neovascularization by topical and subconjunctival tigecycline","volume":"2014","author":"Goktas","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0520","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","article-title":"Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis","volume":"33","author":"Dan","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0525","doi-asserted-by":"crossref","first-page":"e41858","DOI":"10.1371\/journal.pone.0041858","article-title":"Minocycline inhibits alkali burn-induced corneal neovascularization in mice","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2023.115084_b0530","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.addr.2023.115084_b0535","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","article-title":"Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin","volume":"255","author":"Ramchandran","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2023.115084_b0540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mvr.2007.05.005","article-title":"Type IV collagen-derived angiogenesis inhibitors","volume":"74","author":"Mundel","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.addr.2023.115084_b0545","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1158\/0008-5472.CAN-03-1754","article-title":"Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis","volume":"64","author":"Veitonmaki","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2023.115084_b0550","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1073\/pnas.87.17.6624","article-title":"A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin","volume":"87","author":"Good","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b0555","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000226222","article-title":"MT1-MMP-mediated cleavage of decorin in corneal angiogenesis","volume":"46","author":"Mimura","year":"2009","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.addr.2023.115084_b0560","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/137136","article-title":"Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis","volume":"2015","author":"Yoshida","year":"2015","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0565","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","article-title":"Angiostatin inhibits and regresses corneal neovascularization","volume":"120","author":"Ambati","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0570","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000322804","article-title":"Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization","volume":"46","author":"Wang","year":"2011","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.addr.2023.115084_b0575","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.biochi.2012.03.007","article-title":"Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model","volume":"94","author":"Esipov","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.addr.2023.115084_b0580","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1167\/iovs.10-5576","article-title":"Parstatin suppresses ocular neovascularization and inflammation","volume":"51","author":"Huang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0585","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0590","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00417-014-2633-3","article-title":"Anti-neovascular effect of chondrocyte-derived extracellular matrix on corneal alkaline burns in rabbits","volume":"252","author":"Lee","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0595","first-page":"821","article-title":"Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth","volume":"43","author":"Duh","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0600","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.115084_b0605","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1167\/iovs.10-6101","article-title":"Time-lapse in vivo imaging of corneal angiogenesis: the role of inflammatory cells in capillary sprouting","volume":"52","author":"Bourghardt Peebo","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10456-018-9594-9","article-title":"Selective IKK2 inhibitor IMD0354 disrupts NF-kappaB signaling to suppress corneal inflammation and angiogenesis","volume":"21","author":"Lennikov","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.addr.2023.115084_b0615","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICO.0b013e318271cc2a","article-title":"The effect of topical infliximab on corneal neovascularization in rabbits","volume":"32","author":"Kim","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0620","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/02713683.2014.914541","article-title":"Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats","volume":"40","author":"Sari","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0625","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1167\/iovs.08-2732","article-title":"Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist","volume":"50","author":"Lu","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0630","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1158\/0008-5472.CAN-11-2684","article-title":"Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway","volume":"72","author":"Chen","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2023.115084_b0635","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1248\/bpb.b17-00475","article-title":"Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis","volume":"40","author":"Nakahara","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2023.115084_b0640","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1167\/iovs.13-11684","article-title":"Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-beta1\/ERK pathways regulation","volume":"54","author":"Shin","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0645","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004630-199609000-00004","article-title":"Substance P has a role in neurogenic mediation of human burn wound healing","volume":"17","author":"Dunnick","year":"1996","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.addr.2023.115084_b0650","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1167\/iovs.14-14553","article-title":"NK1 receptor antagonists as a new treatment for corneal neovascularization","volume":"55","author":"Bignami","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0655","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","article-title":"Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2","volume":"193","author":"Hernandez","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2023.115084_b0660","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00417-013-2467-4","article-title":"Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits","volume":"251","author":"Bucak","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0665","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ICO.0000000000000336","article-title":"Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits","volume":"34","author":"Park","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0670","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1167\/iovs.12-10064","article-title":"Topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation","volume":"53","author":"Shi","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0675","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1167\/iovs.10-6167","article-title":"Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model","volume":"52","author":"Kubota","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0680","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3181e46ad8","article-title":"The effect of methotrexate on corneal neovascularization in rabbits","volume":"30","author":"Byun","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0685","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1167\/iovs.07-1527","article-title":"Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs","volume":"49","author":"Pakneshan","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0690","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S117425","article-title":"Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats","volume":"11","author":"Li","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.115084_b0695","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00109-015-1277-z","article-title":"Curcumin nanoparticles inhibit corneal neovascularization","volume":"93","author":"Pradhan","year":"2015","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.addr.2023.115084_b0700","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1167\/iovs.11-8722","article-title":"Netrin-1 simultaneously suppresses corneal inflammation and neovascularization","volume":"53","author":"Han","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0705","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/mp300445a","article-title":"Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model","volume":"10","author":"Li","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2023.115084_b0710","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejphar.2014.06.019","article-title":"Largazole, an inhibitor of class I histone deacetylases, attenuates inflammatory corneal neovascularization","volume":"740","author":"Zhou","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2023.115084_b0715","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1167\/iovs.11-8114","article-title":"Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration","volume":"53","author":"Nakao","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0720","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":"Inhibitory effect of triamcinolone acetonide on corneal neovascularization","volume":"244","author":"Murata","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0725","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.steroids.2016.09.001","article-title":"Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis: Antiangiogenic stigmasterol derivatives","volume":"115","author":"Michelini","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.addr.2023.115084_b0730","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","article-title":"Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty","volume":"239","author":"Cursiefen","year":"2001","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0735","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2007.06.004","article-title":"Triamcinolone acetonide in ocular therapeutics","volume":"52","author":"Jermak","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0740","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2023.115084_b0745","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1038\/s41598-021-89818-9","article-title":"An intact complement system dampens cornea inflammation during acute primary HSV-1 infection","volume":"11","author":"Filiberti","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b0750","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.1038\/s41598-017-07129-4","article-title":"Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea","volume":"7","author":"Mirabelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b0755","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13023-021-01890-6","article-title":"Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results","volume":"16","author":"Sanchez-Tabernero","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.addr.2023.115084_b0760","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1158\/1078-0432.CCR-04-2482","article-title":"Antiangiogenic properties of gold nanoparticles","volume":"11","author":"Mukherjee","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2023.115084_b0765","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/ICO.0000000000000343","article-title":"Topically administered gold nanoparticles inhibit experimental corneal neovascularization in mice","volume":"34","author":"Cho","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0770","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1167\/iovs.15-17417","article-title":"Down-Regulation of MicroRNA-184 Is Associated With Corneal Neovascularization","volume":"57","author":"Zong","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0775","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1167\/iovs.05-0105","article-title":"Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis","volume":"46","author":"Berdugo","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0780","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2023.115084_b0785","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/eye.2001.145","article-title":"Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation","volume":"15","author":"Harding","year":"2001","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.addr.2023.115084_b0790","doi-asserted-by":"crossref","unstructured":"G. Verteporfin in Photodynamic Therapy Study, Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1, Ophthalmology, 108 (2001) 841-852.","DOI":"10.1016\/S0161-6420(01)00544-9"},{"key":"10.1016\/j.addr.2023.115084_b0795","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1167\/iovs.02-0572","article-title":"Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization","volume":"44","author":"Holzer","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0800","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2005.11.003","article-title":"Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether","volume":"141","author":"Sheppard","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0805","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/ajt.14874","article-title":"UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival","volume":"18","author":"Hou","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2023.115084_b0810","first-page":"29","article-title":"Treatment of corneal vascularisation by strontium 90 beta plaque","volume":"13","author":"Ainslie","year":"1962","journal-title":"Clin. Symp."},{"key":"10.1016\/j.addr.2023.115084_b0815","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archopht.1967.00980020639013","article-title":"Cryotherapy in corneal vascularization","volume":"77","author":"Mayer","year":"1967","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0820","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s10103-014-1545-0","article-title":"Femtosecond laser-assisted selective reduction of neovascularization in rat cornea","volume":"29","author":"Sidhu","year":"2014","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0825","first-page":"NC01-04","article-title":"Role of Frequency Doubled Nd: Yag Laser in Treatment of Corneal Neovascularisation","volume":"10","author":"Kumar","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.addr.2023.115084_b0830","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0835","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ico.0000248383.09272.ee","article-title":"Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy","volume":"26","author":"Wertheim","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b0840","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2023.115084_b0845","doi-asserted-by":"crossref","first-page":"e30842","DOI":"10.1371\/journal.pone.0030842","article-title":"Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2023.115084_b0850","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00417-021-05394-8","article-title":"miR-340-5p mediates the therapeutic effect of mesenchymal stem cells on corneal neovascularization","volume":"260","author":"Pan","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0855","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5966\/sctm.2011-0037","article-title":"Concise review: limbal stem cell deficiency, dysfunction, and distress","volume":"1","author":"Ahmad","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.addr.2023.115084_b0860","first-page":"988","article-title":"Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy","volume":"7","author":"Guarnieri","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0865","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165840","article-title":"Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers","volume":"21","author":"Olejarz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0870","first-page":"5323","article-title":"Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts","volume":"56","author":"Han","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0875","doi-asserted-by":"crossref","first-page":"28058","DOI":"10.1074\/jbc.M113.470765","article-title":"Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization","volume":"288","author":"Hajrasouliha","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.115084_b0880","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00441-012-1424-6","article-title":"Amniotic membrane: from structure and functions to clinical applications","volume":"349","author":"Mamede","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.addr.2023.115084_b0885","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archopht.126.8.1059","article-title":"Temporary sutureless amniotic membrane patch for acute alkaline burns","volume":"126","author":"Kheirkhah","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0890","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.icu.0000172829.33770.d3","article-title":"Current concepts and techniques in keratoprosthesis","volume":"16","author":"Ilhan-Sarac","year":"2005","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0895","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.1601649113","article-title":"Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b0900","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1301331110","article-title":"Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b0905","doi-asserted-by":"crossref","first-page":"32137","DOI":"10.1038\/srep32137","article-title":"Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis","volume":"6","author":"Mukwaya","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b0910","doi-asserted-by":"crossref","first-page":"e1002126","DOI":"10.1371\/journal.pbio.1002126","article-title":"Endothelial cell self-fusion during vascular pruning","volume":"13","author":"Lenard","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.addr.2023.115084_b0915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s12276-021-00566-2","article-title":"Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies","volume":"53","author":"Mukwaya","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.addr.2023.115084_b0920","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10456-018-9604-y","article-title":"Time-dependent LXR\/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization","volume":"21","author":"Mukwaya","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.addr.2023.115084_b0925","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/08820530902801106","article-title":"Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment","volume":"24","author":"Mauro","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0930","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/joco.joco_153_20","article-title":"Recurrent Pterygium: A Review","volume":"33","author":"Ghiasian","year":"2021","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.addr.2023.115084_b0935","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10456-019-09679-9","article-title":"Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse","volume":"22","author":"Mukwaya","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.addr.2023.115084_b0940","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1167\/iovs.19-27591","article-title":"Repeat Corneal Neovascularization is Characterized by More Aggressive Inflammation and Vessel Invasion Than in the Initial Phase","volume":"60","author":"Mukwaya","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0945","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI24612","article-title":"Rapid vascular regrowth in tumors after reversal of VEGF inhibition","volume":"116","author":"Mancuso","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2023.115084_b0950","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-1281(96)80038-9","article-title":"Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium","volume":"98","author":"Kria","year":"1996","journal-title":"Acta Histochem."},{"key":"10.1016\/j.addr.2023.115084_b0955","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2613.2009.00665.x","article-title":"Correlation between NGF\/TrkA and microvascular density in human pterygium","volume":"90","author":"Ribatti","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b0960","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bjophthalmol-2012-301944","article-title":"Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate","volume":"98","author":"Gumus","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0965","article-title":"The novel role of lymphatic vessels in the pathogenesis of ocular diseases","volume":"101157","author":"Clahsen","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b0970","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00417-017-3651-8","article-title":"Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis","volume":"255","author":"Du","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0975","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1167\/iovs.14-14433","article-title":"Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats","volume":"56","author":"Rho","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0980","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bjophthalmol-2013-303887","article-title":"Regression of mature lymphatic vessels in the cornea by photodynamic therapy","volume":"98","author":"Bucher","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b0985","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/eye.2012.194","article-title":"Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium","volume":"26","author":"Ling","year":"2012","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.addr.2023.115084_b0990","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.115084_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115084_b1000","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exer.2018.01.010","article-title":"Topical drug delivery devices: A review","volume":"168","author":"Bertens","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.survophthal.2017.10.006","article-title":"Gene-based antiangiogenic applications for corneal neovascularization","volume":"63","author":"Liu","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular Drug Delivery: a Comprehensive Review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2023.115084_b1015","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2023.115084_b1020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","article-title":"Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial","volume":"97","author":"Petsoglou","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1542-0124(12)70059-9","article-title":"How does amniotic membrane work?","volume":"2","author":"Tseng","year":"2004","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.addr.2023.115084_b1030","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1167\/iovs.10-5888","article-title":"Inhibition of angiogenesis by HC.HA, a complex of hyaluronan and the heavy chain of inter-alpha-inhibitor, purified from human amniotic membrane","volume":"52","author":"Shay","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1035","article-title":"Preliminary Study on Fish Scale Collagen Lamellar Matrix as Artificial Cornea","volume":"11","author":"Cheng","year":"2021","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.addr.2023.115084_b1040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.01.023","article-title":"Corneal regeneration: A review of stromal replacements","volume":"69","author":"Matthyssen","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2023.115084_b1045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08820530902801478","article-title":"Limbal stem cell deficiency and corneal neovascularization","volume":"24","author":"Lim","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.eye.6700640","article-title":"Limbal autograft and allograft transplantations in patients with corneal burns","volume":"18","author":"Ozdemir","year":"2004","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.addr.2023.115084_b1055","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bjophthalmol-2011-301164","article-title":"Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency","volume":"96","author":"Sangwan","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4103\/0301-4738.109517","article-title":"Oral epithelial cells transplanted on to corneal surface tend to adapt to the ocular phenotype","volume":"62","author":"Gaddipati","year":"2014","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jtos.2017.08.006","article-title":"Midterm outcomes of penetrating keratoplasty after cultivated oral mucosal epithelial transplantation in chemical burn","volume":"15","author":"Baradaran-Rafii","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.addr.2023.115084_b1070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nprot.2017.007","article-title":"Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells","volume":"12","author":"Hayashi","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2023.115084_b1075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1634\/stemcells.2007-0737","article-title":"The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury","volume":"26","author":"Oh","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2023.115084_b1080","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbrc.2007.07.114","article-title":"Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression","volume":"361","author":"Yu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2023.115084_b1085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11373-007-9153-7","article-title":"Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model","volume":"14","author":"Lai","year":"2007","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/hum.2013.079","article-title":"Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin","volume":"25","author":"Parker","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2023.115084_b1095","first-page":"2087","article-title":"Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy","volume":"14","author":"Liu","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2023.115084_b1100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainresbull.2009.07.005","article-title":"Transduction efficiency of AAV 2\/6, 2\/8 and 2\/9 vectors for delivering genes in human corneal fibroblasts","volume":"81","author":"Sharma","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.addr.2023.115084_b1105","doi-asserted-by":"crossref","unstructured":"J. Xu, J. Wang, Y. Chen, Y. Hou, J. Hu, G. Wang, Recent advances of natural and bioengineered extracellular vesicles and their application in vascular regeneration, Regen Biomater, 9 (2022) rbac064.","DOI":"10.1093\/rb\/rbac064"},{"key":"10.1016\/j.addr.2023.115084_b1110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","article-title":"Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity","volume":"109","author":"Sahoo","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2023.115084_b1115","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1120","doi-asserted-by":"crossref","first-page":"40548","DOI":"10.1038\/srep40548","article-title":"Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b1125","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.753879","article-title":"Ocular Wnt\/beta-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization","volume":"9","author":"Zhong","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2023.115084_b1130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2014.07.049","article-title":"Extracellular vesicles as drug delivery systems: lessons from the liposome field","volume":"195","author":"van der Meel","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.115084_b1135","doi-asserted-by":"crossref","first-page":"2003559","DOI":"10.1002\/adfm.202003559","article-title":"Recent Advances of Cell Membrane-Coated Nanomaterials for Biomedical Applications","volume":"30","author":"Liu","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2023.115084_b1140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030525","article-title":"Iontophoresis of Biological Macromolecular Drugs","volume":"14","author":"Hasan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.115084_b1145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/108729003321629647","article-title":"Delivery of antisense oligonucleotide to the cornea by iontophoresis","volume":"13","author":"Berdugo","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.addr.2023.115084_b1150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1442-9071.2009.02179.x","article-title":"Gene therapy for diseases of the cornea - a review","volume":"38","author":"Williams","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.addr.2023.115084_b1155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.exer.2009.08.001","article-title":"Electrically assisted delivery of macromolecules into the corneal epithelium","volume":"89","author":"Hao","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1167\/iovs.05-0889","article-title":"Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles","volume":"47","author":"Sonoda","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/418290a","article-title":"Targeted transfection by femtosecond laser","volume":"418","author":"Tirlapur","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.115084_b1170","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/gt.2009.41","article-title":"Efficient lentiviral gene transfer into corneal stroma cells using a femtosecond laser","volume":"16","author":"Bemelmans","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2023.115084_b1175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00417-005-0070-z","article-title":"Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense","volume":"244","author":"Bauer","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1442-9071.2000.00255.x","article-title":"Corneal endothelial cell nuclei are damaged after DNA transfer using a gene gun","volume":"28","author":"Klebe","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.addr.2023.115084_b1185","first-page":"2494","article-title":"Vector delivery technique affects gene transfer in the cornea in vivo","volume":"16","author":"Mohan","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2023.115084_b1190","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1167\/iovs.14-15257","article-title":"Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization","volume":"55","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1195","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.115084_b1200","doi-asserted-by":"crossref","first-page":"20210170","DOI":"10.1002\/EXP.20210170","article-title":"Microneedle system for tissue engineering and regenerative medicine","volume":"3","author":"Zhang","year":"2023","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.addr.2023.115084_b1205","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.drudis.2015.01.013","article-title":"Raghu Raj Singh, Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye","volume":"20","author":"Yellepeddi","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2023.115084_b1210","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1167\/iovs.17-22904","article-title":"Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival","volume":"58","author":"Hou","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2019.123706","article-title":"Self-Assembly of amphiphilic BODIPY derivative and its nanoparticles as a photosensitizer for photodynamic therapy in corneal neovascularization","volume":"579","author":"Jiang","year":"2019","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.addr.2023.115084_b1220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archopht.1975.01010020797012","article-title":"Induced corneal vascularization remission with argon laser therapy","volume":"93","author":"Reed","year":"1975","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.9.13.16","article-title":"Photo-Mediated Ultrasound Therapy for the Treatment of Corneal Neovascularization in Rabbit Eyes","volume":"9","author":"Qin","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.addr.2023.115084_b1230","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/acsbiomaterials.0c01347","article-title":"Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses","volume":"6","author":"Rodrigues","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2023.115084_b1235","doi-asserted-by":"crossref","first-page":"20210099","DOI":"10.1002\/EXP.20210099","article-title":"Light responsive nucleic acid for biomedical application","volume":"2","author":"Chen","year":"2022","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.addr.2023.115084_b1240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.exer.2016.04.016","article-title":"Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy","volume":"147","author":"Cejkova","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119835","article-title":"Curcumin-loaded proniosomal gel as a biofreindly alternative for treatment of ocular inflammation: In-vitro and in-vivo assessment","volume":"589","author":"Aboali","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.115084_b1250","doi-asserted-by":"crossref","unstructured":"J.I. Luchs, D.S. Nelinson, J.I. Macy, L.A.C.S. Group, Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry, Cornea, 29 (2010) 1417-1427.","DOI":"10.1097\/ICO.0b013e3181e3f05b"},{"key":"10.1016\/j.addr.2023.115084_b1255","doi-asserted-by":"crossref","unstructured":"M.A.F. Z, A. Vangala, M. Longman, K.A. Khaled, A.K. Hussein, O.H. El-Garhy, R.G. Alany, Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies, Eur. J. Pharm. Biopharm. 114 (2017) 119-134.","DOI":"10.1016\/j.ejpb.2017.01.008"},{"key":"10.1016\/j.addr.2023.115084_b1260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2016.07.005","article-title":"Development of cationic nanocrystals for ocular delivery","volume":"107","author":"Romero","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2023.115084_b1265","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3109\/10717544.2016.1138342","article-title":"A review on therapeutic contact lenses for ocular drug delivery","volume":"23","author":"Maulvi","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2023.115084_b1270","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.115084_b1275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40486-019-0101-x","article-title":"Magnetic micropump embedded in contact lens for on-demand drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Micro Nano Syst. Lett."},{"key":"10.1016\/j.addr.2023.115084_b1280","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.2147\/IJN.S375570","article-title":"An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.115084_b1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114721","article-title":"Nano-based eye drop: Topical and noninvasive therapy for ocular diseases","volume":"194","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.115084_b1290","doi-asserted-by":"crossref","DOI":"10.1039\/D3BM00505D","article-title":"Nano-based ocular drug delivery systems: an insight into the preclinical\/clinical studies and their potential in the treatment of posterior ocular diseases","author":"Su","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1295","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1167\/iovs.07-0389","article-title":"Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins","volume":"49","author":"Sugisaki","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1300","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/ICO.0b013e318206c893","article-title":"Gene transfer using micellar nanovectors inhibits corneal neovascularization in vivo","volume":"30","author":"Iriyama","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b1305","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1167\/iovs.06-0853","article-title":"Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis","volume":"48","author":"Jani","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1310","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1167\/iovs.11-9139","article-title":"Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization","volume":"53","author":"Qazi","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1315","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/45\/455104","article-title":"Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties","volume":"20","author":"Kemp","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2023.115084_b1320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2016.03.061","article-title":"The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system","volume":"143","author":"Chen","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2023.115084_b1325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10717544.2021.2021323","article-title":"Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2023.115084_b1330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nano.2019.01.001","article-title":"Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization","volume":"17","author":"Wang","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2023.115084_b1335","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1039\/D1TB00229E","article-title":"Bioadhesive glycosylated nanoformulations for extended trans-corneal drug delivery to suppress corneal neovascularization","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2023.115084_b1340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2016.09.005","article-title":"Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application","volume":"109","author":"Lai","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.115084_b1345","doi-asserted-by":"crossref","unstructured":"M. Qiu, Y. Duo, W. Liang, Y. Yang, B. Zhang, Z. Xie, X. Yang, G. Wang, N. Xie, G. Nie, O.A. Alhartomy, A.A. ALGhamdi, S. Wageh, Y. Cao, H. Zhang, Nanopoxia: Targeting Cancer Hypoxia by Antimonene-Based Nanoplatform for Precision Cancer Therapy, Adv. Functional Mater., 31 (2021) 2104607.","DOI":"10.1002\/adfm.202104607"},{"key":"10.1016\/j.addr.2023.115084_b1350","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11095-020-02857-1","article-title":"Preparation and Evaluation of Cubosomes\/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis","volume":"37","author":"Gaballa","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.115084_b1355","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.addr.2023.115084_b1360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.18433\/J3H02C","article-title":"Single-walled carbon nanotubes mediated neovascularity targeted antitumor drug delivery system","volume":"16","author":"Chen","year":"2013","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1365","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actbio.2015.01.021","article-title":"Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy","volume":"16","author":"Wang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2023.115084_b1370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnci\/52.2.413","article-title":"Tumor growth and neovascularization: an experimental model using the rabbit cornea","volume":"52","author":"Gimbrone","year":"1974","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.addr.2023.115084_b1375","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.472760","article-title":"Angiogenesis in the mouse cornea","volume":"205","author":"Muthukkaruppan","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.115084_b1380","first-page":"351","article-title":"A corneal micropocket assay for angiogenesis in the rat eye","volume":"21","author":"Fournier","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.02.005","article-title":"Alkali burn versus suture-induced corneal neovascularization in C57BL\/6 mice: an overview of two common animal models of corneal neovascularization","volume":"121","author":"Giacomini","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1390","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10456-011-9223-3","article-title":"Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model","volume":"14","author":"Peebo","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.addr.2023.115084_b1395","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199004000-00011","article-title":"Ultrastructural features of contact lens-induced deep corneal neovascularization and associated stromal leukocytes","volume":"9","author":"Madigan","year":"1990","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b1400","first-page":"864","article-title":"Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1alpha in a mouse model of closed eye contact lens wear","volume":"18","author":"Chen","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2023.115084_b1405","first-page":"1261","article-title":"Establishment of the New Zealand white rabbit animal model of fatty keratopathy associated with corneal neovascularization, Open","volume":"16","author":"Gao","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2023.115084_b1410","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1038\/s41598-019-48811-z","article-title":"Application of corneal injury models in dual fluorescent reporter transgenic mice to understand the roles of the cornea and limbus in angiogenic and lymphangiogenic privilege","volume":"9","author":"Gao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b1415","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"Chen","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1420","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0000000000003242","article-title":"Novel Animal Model of Limbal Stem Cell Deficiency Induced by Forcing Eye-Open at Birth","author":"Wang","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b1425","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41598-018-19578-6","article-title":"A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision","volume":"8","author":"Shinomiya","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.115084_b1430","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2015.09.010","article-title":"Development of a novel in vivo corneal fibrosis model in the dog","volume":"143","author":"Gronkiewicz","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1435","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.05.005","article-title":"Inflammation, vascularization and goblet cell differences in LSCD: Validating animal models of corneal alkali burns","volume":"185","author":"Kethiri","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1440","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1167\/iovs.12-10725","article-title":"A mouse model of limbal stem cell deficiency induced by topical medication with the preservative benzalkonium chloride","volume":"54","author":"Lin","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1445","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.06-0728","article-title":"New tools for the evaluation of toxic ocular surface changes in the rat","volume":"48","author":"Pauly","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1450","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea","volume":"4","author":"Mahoney","year":"1985","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1455","first-page":"1888","article-title":"Effects of HGF and KGF gene silencing on vascular endothelial growth factor and its receptors in rat ultraviolet radiation-induced corneal neovascularization","volume":"43","author":"He","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2023.115084_b1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/IR:25:1:01","article-title":"Experimental corneal allograft rejection","volume":"25","author":"Gebhardt","year":"2002","journal-title":"Immunol. Res."},{"key":"10.1016\/j.addr.2023.115084_b1465","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2015.78","article-title":"Ocular surgical models for immune and angiogenic responses","volume":"2","author":"Inomata","year":"2015","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.addr.2023.115084_b1470","doi-asserted-by":"crossref","first-page":"11302","DOI":"10.1038\/ncomms11302","article-title":"Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.115084_b1475","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","article-title":"Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis","volume":"247","author":"Saravia","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1480","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1440-1711.2002.01094.x","article-title":"Macrophage inflammatory protein-2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice","volume":"80","author":"Xue","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.addr.2023.115084_b1485","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ebiom.2019.05.026","article-title":"Three kinds of corneal host cells contribute differently to corneal neovascularization","volume":"44","author":"Yu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.addr.2023.115084_b1490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00417-010-1442-6","article-title":"Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice","volume":"249","author":"Shi","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1495","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF00946944","article-title":"Intracorneal bovine albumin: an immunologic model of corneal angiogenesis","volume":"235","author":"Damms","year":"1997","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1500","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2010.124","article-title":"Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?","volume":"128","author":"Goyal","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1505","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jtos.2021.10.006","article-title":"Eyelid blood vessel and meibomian gland changes in a sclerodermatous chronic GVHD mouse model","volume":"26","author":"Yang","year":"2022","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.addr.2023.115084_b1510","first-page":"1077","article-title":"Evaluation of a rat meibomian gland dysfunction model induced by closure of meibomian gland orifices","volume":"11","author":"Dong","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1515","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00417-014-2592-8","article-title":"Effect of porcine chondrocyte-derived extracellular matrix on the pterygium in mouse model","volume":"252","author":"Lee","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1520","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1463-5224.2005.00351.x","article-title":"Corneal vascularization in the Florida manatee (Trichechus manatus latirostris) and three-dimensional reconstruction of vessels","volume":"8","author":"Harper","year":"2005","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.addr.2023.115084_b1525","first-page":"1872","article-title":"Simulation of corneal neovascularization by inverted diffusion limited aggregation","volume":"34","author":"Landini","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1530","doi-asserted-by":"crossref","first-page":"1900328","DOI":"10.1002\/adhm.201900328","article-title":"Human Ocular Angiogenesis-Inspired Vascular Models on an Injection-Molded Microfluidic Chip","volume":"8","author":"Ko","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2023.115084_b1535","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2023.115084_b1540","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1167\/iovs.14-15430","article-title":"Transgenic mouse models of corneal neovascularization: new perspectives for angiogenesis research","volume":"55","author":"Kather","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1545","first-page":"397","article-title":"Corn1: a mouse model for corneal surface disease and neovascularization","volume":"37","author":"Smith","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1550","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9440(10)62355-3","article-title":"Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling","volume":"166","author":"Cursiefen","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b1555","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2023.115084_b1560","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1167\/iovs.02-0576","article-title":"Corneal abnormalities in Pax6+\/- small eye mice mimic human aniridia-related keratopathy","volume":"44","author":"Ramaesh","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1565","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1167\/iovs.10-6726","article-title":"Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation","volume":"52","author":"Davis","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1570","doi-asserted-by":"crossref","first-page":"e63674","DOI":"10.1371\/journal.pone.0063674","article-title":"Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing","volume":"8","author":"Chatterjee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2023.115084_b1575","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1073\/pnas.1109540109","article-title":"Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth","volume":"109","author":"Seo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2023.115084_b1580","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1167\/iovs.16-21217","article-title":"Foxc1 and Foxc2 in the Neural Crest Are Required for Ocular Anterior Segment Development","volume":"58","author":"Seo","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1585","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1167\/iovs.12-9676","article-title":"KLEIP deficiency in mice causes progressive corneal neovascular dystrophy","volume":"53","author":"Hahn","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1590","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1096\/fj.07-9998com","article-title":"RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice","volume":"22","author":"Dou","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b1595","first-page":"948","article-title":"Vascularization of corneas of hairless mutant mice","volume":"31","author":"Niederkorn","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1600","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2353\/ajpath.2010.090655","article-title":"ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells","volume":"176","author":"Koo","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b1605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9440(10)62956-2","article-title":"X-linked anhidrotic ectodermal dysplasia disruption yields a mouse model for ocular surface disease and resultant blindness","volume":"167","author":"Cui","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b1610","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.devcel.2007.06.012","article-title":"Corneal epithelial cell fate is maintained during repair by Notch1 signaling via the regulation of vitamin A metabolism","volume":"13","author":"Vauclair","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.addr.2023.115084_b1615","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajpath.2017.09.016","article-title":"Loss of beta Epithelial Sodium Channel Function in Meibomian Glands Produces Pseudohypoaldosteronism 1-Like Ocular Disease in Mice","volume":"188","author":"Yu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b1620","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1167\/iovs.17-22658","article-title":"A Novel C-Terminal Mutation in Gsdma3 (C+\/H-) Leads to Alopecia and Corneal Inflammatory Response in Mice","volume":"59","author":"Swirski","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1625","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151078","article-title":"Epithelial stem cell homeostasis in Meibomian gland development, dysfunction, and dry eye disease","volume":"6","author":"Tchegnon","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2023.115084_b1630","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1096\/fj.201900725R","article-title":"On the pivotal role of Elovl3\/ELOVL3 in meibogenesis and ocular physiology of mice","volume":"33","author":"Butovich","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b1635","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/ATVBAHA.120.315003","article-title":"Loss of Down Syndrome Critical Region-1 Mediated-Hypercholesterolemia Accelerates Corneal Opacity Via Pathological Neovessel Formation","volume":"40","author":"Muramatsu","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2023.115084_b1640","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1167\/iovs.15-18103","article-title":"AP-2beta Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development","volume":"57","author":"Chen","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1645","doi-asserted-by":"crossref","first-page":"e0184916","DOI":"10.1371\/journal.pone.0184916","article-title":"Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2023.115084_b1650","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1038\/ncomms10824","article-title":"MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis","volume":"7","author":"Wong","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.115084_b1655","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67315","article-title":"Canonical NF-kappaB signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid","volume":"10","author":"Yu","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.addr.2023.115084_b1660","first-page":"131","article-title":"Ocular inflammation in HLA-B27 transgenic mice reveals a potential role for MHC class I in corneal immune privilege","volume":"21","author":"Lin","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2023.115084_b1665","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1167\/iovs.13-13685","article-title":"STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis","volume":"55","author":"Turner","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1670","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2023.115084_b1675","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/ICO.0b013e31817780b6","article-title":"Genetic ablation of CD36 induces age-related corneal neovascularization","volume":"27","author":"Mwaikambo","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.115084_b1680","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI71488","article-title":"LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis","volume":"124","author":"Nakamura","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2023.115084_b1685","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ydbio.2009.07.028","article-title":"Conditional deletion of Cited2 results in defective corneal epithelial morphogenesis and maintenance","volume":"334","author":"Chen","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.addr.2023.115084_b1690","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1167\/iovs.14-15155","article-title":"Eyelid closure in embryogenesis is required for ocular adnexa development","volume":"55","author":"Meng","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.115084_b1695","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1096\/fj.201700947R","article-title":"Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice","volume":"32","author":"Sassa","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b1700","doi-asserted-by":"crossref","first-page":"13792","DOI":"10.1096\/fj.202001191R","article-title":"Deficiency in Acyl-CoA: Wax Alcohol Acyltransferase 2 causes evaporative dry eye disease by abolishing biosynthesis of wax esters","volume":"34","author":"Widjaja-Adhi","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b1705","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/02713683.2011.631720","article-title":"The role of dyslipidemia on ocular surface, lacrimal and meibomian gland structure and function","volume":"37","author":"Modulo","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2023.115084_b1710","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jtos.2019.06.002","article-title":"Hyperlipidemia induces meibomian gland dysfunction","volume":"17","author":"Bu","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.addr.2023.115084_b1715","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.ajpath.2020.08.017","article-title":"Corneal Opacity Induced by Light in a Mouse Model of Gelatinous Drop-Like Corneal Dystrophy","volume":"190","author":"Nagahara","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2023.115084_b1720","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1096\/fj.202001020R","article-title":"The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.115084_b1725","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.1038\/ncomms12034","article-title":"PACAP suppresses dry eye signs by stimulating tear secretion","volume":"7","author":"Nakamachi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.115084_b1730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ydbio.2011.05.005","article-title":"Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cells","volume":"356","author":"Kenchegowda","year":"2011","journal-title":"Dev. Biol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2300399X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2300399X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:42:18Z","timestamp":1759210938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X2300399X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":346,"alternative-id":["S0169409X2300399X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.115084","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up-to-date molecular medicine strategies for management of ocular surface neovascularization","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.115084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115084"}}